Skip to content Skip to search

Republish This Story

* Please read before republishing *

We’re happy to make this story available to republish for free under an Attribution-NonCommercial-NoDerivatives Creative Commons license as long as you follow our republishing guidelines, which require that you credit The 19th and retain our pixel. See our full guidelines for more information.

To republish, simply copy the HTML at right, which includes our tracking pixel, all paragraph styles and hyperlinks, the author byline and credit to The 19th. Have questions? Please email [email protected].

— The Editors

Loading...

Modal Gallery

/
Donate to our newsroom

Menu

Topics

  • Abortion
  • Politics
  • Education
  • LGBTQ+
  • Caregiving
  • Environment & Climate
  • Business & Economy
View all topics

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

  • Latest Stories
  • Our Mission
  • Our Team
  • Ways to Give
  • Search
  • Contact
Donate
Home

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

Topics

  • Abortion
  • Politics
  • Education
  • LGBTQ+
  • Caregiving
  • Environment & Climate
  • Business & Economy
View all topics

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

  • Latest Stories
  • Our Mission
  • Our Team
  • Ways to Give
  • Search
  • Contact

We’re an independent, nonprofit newsroom reporting on gender, politics and policy. Read our story.

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

Become a member

The 19th thanks our sponsors. Become one.

Abortion

Two major pharmacies say they plan to offer medication abortions. Here’s what that could mean.

The federal government will let retail pharmacies provide mifepristone, which helps end pregnancies, to patients with a prescription. But it’s not clear how widespread the impact will be.

A pedestrian is reflected in the window of a CVS Pharmacy.
(Brendan Smialowski/AFP/Getty Images)

Shefali Luthra

Reproductive Health Reporter

Published

2023-01-05 09:42
9:42
January 5, 2023
am

Republish this story

Share

  • Bluesky
  • Facebook
  • Email

Republish this story

Medication abortion is poised to become more easily available in states where it is legal, after the country’s two biggest retail pharmacy chains said they will take steps to offer it in the wake of new guidance from the Food and Drug Administration.

The guidance, released Tuesday night, for the first time allows brick-and-mortar retail pharmacies that undergo government certification to dispense a medication known as mifepristone, one of two medications used to end a first-trimester pregnancy. Patients will still need a physician’s prescription.

The change, welcomed by the American College of Obstetricians and Gynecologists representing gynecologists and obstetricians, as well as by abortion rights organizations, could have a significant impact. Until December 2021, mifepristone could be dispensed in person only with the supervision of a certified clinician. In the past year, the federal government shifted to allow specialty pharmacies to mail mifepristone to patients who had a prescription. But it has not been available in average retail pharmacies.

The 19th thanks our sponsors. Become one.

In statements to The 19th, both CVS and Walgreens — the nation’s two biggest retail pharmacy chains — confirmed that they intend to undergo the federal certification process to provide mifepristone. But neither company would specify when it will begin or complete that process. Smaller pharmacies could also undergo the certification process. 

And it is not clear how many retail pharmacies under either company will actually participate once the certification process is complete. A spokesperson for Walgreens said the company is still “evaluating our pharmacy network in terms of where we normally dispense products that have extra FDA requirements.” 

  • Abortion dashboard:
    Greyed out map with text that reads
  • Abortion dashboard: What abortion looks like in every state — right now

The impact is also likely to be limited to states where abortion within the first trimester — which ends at 13 weeks — remains legal. A spokesperson for CVS said the company will seek certification to provide mifepristone “where legally permissible,” and Walgreens said it will dispense the drug “consistent with federal and state laws.” 

Currently, near-total or total abortion bans are in effect in 13 states; abortions are not permitted in Georgia for people past six weeks of pregnancy. Since Roe v. Wade was overturned this summer, thousands of people who live in states with abortion bans have been traveling to other parts of the country to get an abortion. 

Neither CVS nor Walgreens responded to questions about whether their pharmacies would factor in patients’ home addresses when filling prescriptions for medication abortion — a meaningful concern for people who may travel from a state where abortion is illegal to seek care somewhere else. 

  • More abortion coverage
    A woman supporting abortion rights reacts to an anti-abortion protest outside the South Carolina Statehouse.
  • Here’s how states plan to limit abortion — even where it is already banned
  • Label change for mifepristone could reduce barriers to care for miscarriages, advocates say in petition to FDA
  • Abortion bans are barring people from life-saving pregnancy care, medical groups warn

Medication abortion dispensation has been subject to heated political debate, and that is unlikely to end here. “We might see additional litigation on this issue,” Jennifer Klein, director of the White House Gender Policy Council, told The 19th. 

As of 2021, medication abortions have accounted for the majority of abortions in the country. Medication abortion is approved in the United States for up to 10 weeks pregnancy, though the World Health Organization endorses the practice for people through their 12th week. 

The federal government made another move this week that could address how patients access medication abortion. On Tuesday, the Department of Justice issued a legal opinion arguing that the decades-old Comstock Act — which prohibits sending “indecent” or “immoral” material through mail — does not apply to mailing mifepristone or misoprostol, the other medication used in medication abortions. “There are manifold ways in which recipients in every state may lawfully use such drugs,” a DOJ memo argued. 

In theory, that too could expand access to medication abortions, which some people have had forwarded through the mail to them in states with abortion bans. But it’s not clear whether the lack of federal prosecution would protect people if they are found to have violated individual state laws.

Sign up for more news and context delivered to your inbox, daily

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting…

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

Preview of the daily newsletter from The 19th

It’s also not clear what further action the White House or federal government might take on the issue. President Joe Biden has called on Congress to pass a law codifying the abortion rights protections formerly enshrined by Roe v. Wade. But such legislation is unlikely to pass, especially with Republicans holding a majority in the House of Representatives.

“It really is true you can’t replace a 50-year precedent with executive actions,” Klein said. But, she added, “we will continue to look for any and all executive actions that we think will continue to improve people’s access to abortion.”

Republish this story

Share

  • Bluesky
  • Facebook
  • Email

Recommended for you

A woman holds a pack of pills used for abortions.
CVS and Walgreens will start selling abortion pills this month
President Biden speaks in front of a microphone
Biden signs executive order on abortion access and legal backing
Joe Biden delivers remarks in front of the White House.
Experts say Biden could use executive powers to protect abortion access
two packets of abortion medication pills
Majority of abortions in 2020 were via medication, new data analysis shows

The 19th News(letter)

News that represents you, in your inbox every weekday.

You have been subscribed!

Please complete the following CAPTCHA to be confirmed. If you have any difficulty, contact [email protected] for help.

Submitting...

Uh-oh! Something went wrong. Please email [email protected] to subscribe.

This email address might not be capable of receiving emails (according to Bouncer). You should try again with a different email address. If you have any questions, contact us at [email protected].

Become a member

Explore more coverage from The 19th
Abortion Politics Education LGBTQ+ Caregiving
View all topics

Our newsroom's Spring Member Drive is here!

Learn more about membership.

  • Transparency
    • About
    • Team
    • Contact
    • Privacy Policy
    • Community Guidelines
  • Newsroom
    • Latest Stories
    • 19th News Network
    • Podcast
    • Events
    • Careers
    • Fellowships
  • Newsletters
    • Daily
    • Weekly
    • The Amendment
    • Event Invites
  • Support
    • Ways to Give
    • Sponsorship
    • Republishing
    • Volunteer

The 19th is a reader-supported nonprofit news organization. Our stories are free to republish with these guidelines.